Ignite Creation Date:
2024-05-06 @ 2:59 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04486833
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2020-07-22
Brief Title:
Quaratusugene Ozeplasmid Reqorsa and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Sponsor:
Genprex Inc
Organization:
Genprex Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-03
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-22
First Submit QC Date:
July 22 2020
Study First Post Date:
2020-07-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-15
Last Update Post Date:
2024-06-26
Last Update Post Date Type:
ACTUAL